PT - JOURNAL ARTICLE AU - Supasiri, Thanan AU - Salakshna, Nuntida AU - Pongpirul, Krit TI - Short Practical Regimen of Acupuncture for Melasma: A Prospective Cohort Study in a Tertiary Hospital in Thailand AID - 10.1101/2021.02.04.21251151 DP - 2021 Jan 01 TA - medRxiv PG - 2021.02.04.21251151 4099 - http://medrxiv.org/content/early/2021/08/19/2021.02.04.21251151.short 4100 - http://medrxiv.org/content/early/2021/08/19/2021.02.04.21251151.full AB - Background Melasma is a common skin pigmentation disorder. Acupuncture shows benefits for patients with melasma, although no standardized method or an optimal number of sessions have been determined.Objective To comparatively assess clinical outcomes of melasma between five versus ten standard acupuncture sessions.Methods We performed a prospective observational cohort study in all melasma patients at the Acupuncture Clinic, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. All patients were treated with acupuncture procedures twice a week and were evaluated after the fifth and the tenth sessions of acupuncture, with a one-week follow-up after the last session. Participants were divided into two treatment groups: Groups A and B received five and ten acupuncture sessions respectively. Melasma outcomes were assessed by using the Melanin Index (MI), Melasma Area and Severity Index (MASI), patient-reported improvement scores, and acupuncture-related adverse events.Results Of 113 participants, 67 received five sessions of acupuncture treatment while 39 received ten sessions. 7 participants did not finish treatment. At one week after five sessions of acupuncture in Group A, the mean MI decreased by 28.7 (95%CI -38.5 to -18.8, p<0.001), whereas the median MASI decreased by 3.4 (−6.9, -1.2), p<0.001) points. At one week after ten sessions of acupuncture in Group B, the mean MI decreased by 31.3 (95%CI -45.0 to -17.6, p<0.001), whereas the median MASI decreased by 5.4 (−9.9, -3.0), p<0.001) points. The first five sessions of acupuncture had a higher effect on the change in magnitude than the last five sessions, although there was no statistically significant difference. Twenty-nine participants reported minor side effects, mostly consisting of persistent pain and small hematoma. Group B had a risk ratio (RR) of having adverse events 1.8 times (95% CI 1.0-3.4, p-value = 0.05) compared to group A.Conclusion Short acupuncture regimen of 5 to 10 sessions in melasma seems to be effective, practical, and high patient satisfaction with minor side effects.What is already known about this subject?Acupuncture has effectively improved melasma condition at low cost with minimal side effects.Traditionally, one acupuncture course comprises of 10 sessions for a chronic condition but dose-response evidence of acupuncture for melasma has been lacking.Number of acupuncture sessions performed in various randomized controlled trial varied from 21 to 60 over 4-16 weeks.What are the new findings?Five sessions of acupuncture improved Melanin Index (MI) by 28.7 and Melasma Area and Severity Index (MASI) by 3.4 points.Ten sessions of acupuncture improved MI by 31.3 and MASI by 5.4 points, of which the improvement was mainly from the first five sessions.Short acupuncture regimen of 5 to 10 sessions in melasma seems to be effective, practical, and high patient satisfactionHow might it impact on clinical practice in the foreseeable future?Dose-response study has not been common but could have clinical and financial implications.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study was registered on August 19, 2018, before recruiting the first case, with the Thai Clinical Trials Registry, Identification Number TCTR20180824002.Funding StatementThis study was funded by the Ratchadapiseksompotch Fund, Faculty of Medicine, Chulalongkorn University, grant number RA 060/60 and RA-MF-12/62.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Institutional Review Board (IRB), Faculty of Medicine, Chulalongkorn University (IRB No.544/2559). Each participant provided written informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available upon reasonable request.